跳至主要内容
临床试验/CTRI/2016/10/007356
CTRI/2016/10/007356招募中1 期

Phase 1 trial of poly (lactide-co-glycolide( (PLG) nanoparticles encapsulating antitubercular drugs (isoniazid, rifmapicin, pyrazinamide and ethambutol).

DRUGS AND PHARMACEUTICALS RESEARCH PROGRAMME or DPRP0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •Within 20% of ideal weight
  • •Willing to give written informed consent
  • •Medical history, physical examination, routine hematology, clinical chemistry, HIV, urinalysis, visual acuity and stool examination for occult blood

排除标准

  • •Smokers, alcoholics or taking any drugs of abuse
  • •Known contraindication to any of the study drugs
  • •HIV / HBsAg positive individuals
  • •Participated in any IND study within the previous 6 months or in a confirmatory trial in the previous 3 months

研究者

发起方
DRUGS AND PHARMACEUTICALS RESEARCH PROGRAMME or DPRP

相似试验